谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

710P Phase II Trial of Lenvatinib (LEN) + Pembrolizumab (PEMBRO) for Progressive Disease after PD-1/PD-L1 Immune Checkpoint Inhibitor (ICI) in Metastatic Clear Cell (mcc) Renal Cell Carcinoma (RCC): Results by Independent Imaging Review and Subgroup Analyses

C-H. Lee,A. Y. Shah,J. J. Hsieh,A. Rao,A. Pinto,M. A. Bilen,A. L. Cohn,C. Di Simone,D. R. Shaffer,R. Girones Sarrio,S. Gunnestad Ribe,J. Wu,E. Schmidt,P. Kubiak,C. E. Okpara,A. D. Smith,R. J. Motzer

ANNALS OF ONCOLOGY（2020）

引用 3|浏览56
暂无评分
关键词
Renal Cell Carcinoma,Gemcitabine,Treatment
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要